Соединенные Штаты - английский - NLM (National Library of Medicine)

physicians total care, inc. - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine hydrochloride 665 ug - patanase nasal spray is an h1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older. none. pregnancy category c: no adequate and well-controlled studies in pregnant women have been conducted. animal reproductive studies in rats and rabbits revealed treatment-related effects on fetuses or pups. because animal studies are not always predictive of human responses, patanase nasal spray should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the embryo or fetus. a decrease in the number of live fetuses was observed in rabbits and rats at the oral olopatadine doses approximately 88 times and 100 times the maximum recommended human dose (mrhd) and above, respectively, for adults on a mg/m2 basis. in rats, viability and body weights of pups were reduced on day 4 post partum at the oral dose approximately 100 times the mrhd for adults on a mg/m2 basis, but no effect on viability wa

Соединенные Штаты - английский - NLM (National Library of Medicine)

alcon laboratories, inc. - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine 600 ug - patanase is indicated for the relief of the symptoms of seasonal allergic rhinitis (sar) in adults and pediatric patients 6 years of age and older. none. risk summary published data from postmarketing experience with antihistamines, with similar mechanism of action to patanase, have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. however, there are no published human data specific to patanase. in animal reproductive studies, oral administration of olopatadine hydrochloride to pregnant rats and rabbits caused a decrease in the number of live fetuses at maternal doses approximately 110 and 1460 times the maximum recommended human daily intranasal dose (mrhdid) on a mg/m2 basis, respectively (see data ). the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss or other adverse outcomes. in the u.s. general population, the background r

Соединенные Штаты - английский - NLM (National Library of Medicine)

gland pharma limited - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - antihistamine and redness reliever temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander • if solution changes color or becomes cloudy  • if you are sensitive to any ingredient in this product • to treat contact lens related irritation you experience:   - eye pain - changes in vision - increased redness of the eye - itching worsens or lasts for more than 72 hours

Соединенные Штаты - английский - NLM (National Library of Medicine)

jubilant hollisterstier general partnership - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine 1 mg in 1 ml

Соединенные Штаты - английский - NLM (National Library of Medicine)

perrigo new york inc - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine 665 ug

Соединенные Штаты - английский - NLM (National Library of Medicine)

physicians total care, inc. - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine hydrochloride 2 mg in 1 ml - pataday™ solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis. hypersensitivity to any components of this product.

Соединенные Штаты - английский - NLM (National Library of Medicine)

alcon laboratories, inc. - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine 2 mg in 1 ml - pataday™ solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis. none. teratogenic effects: pregnancy category c olopatadine was found not to be teratogenic in rats and rabbits. however, rats treated at 600 mg/kg/day, or 150,000 times the mrohd and rabbits treated at 400 mg/kg/day, or approximately 100,000 times the mrohd, during organogenesis showed a decrease in live fetuses. in addition, rats treated with 600 mg/kg/day of olopatadine during organogenesis showed a decrease in fetal weight. further, rats treated with 600 mg/kg/day of olopatadine during late gestation through the lactation period showed a decrease in neonatal survival and body weight. there are, however, no adequate and well- controlled studies in pregnant women. because animal studies are not always predictive of human responses, this drug should be used in pregnant women only if the potential benefit to the mother justifies the potential risk to the embryo or fetus. olopatadine has been identified

Соединенные Штаты - английский - NLM (National Library of Medicine)

gland pharma limited - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - antihistamine temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander - if solution changes color or becomes cloudy   - if you are sensitive to any ingredient in this product - to treat contact lens related irritation you experience:   - eye pain - changes in vision - increased redness of the eye - itching worsens or lasts for more than 72 hours

Соединенные Штаты - английский - NLM (National Library of Medicine)

chain drug marketing association inc - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - antihistamine temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander - if solution changes color or becomes cloudy   - if you are sensitive to any ingredient in this product - to treat contact lens related irritation you experience:   - eye pain - changes in vision - increased redness of the eye - itching worsens or lasts for more than 72 hours

Соединенные Штаты - английский - NLM (National Library of Medicine)

chain drug marketing association inc - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - antihistamine and redness reliever temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander • if solution changes color or becomes cloudy  • if you are sensitive to any ingredient in this product • to treat contact lens related irritation you experience:   - eye pain - changes in vision - increased redness of the eye - itching worsens or lasts for more than 72 hours